Equities

QHSLab Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
USAQ:QBB

QHSLab Inc

Actions
  • Price (USD)0.7242
  • Today's Change0.00 / 0.00%
  • Shares traded53.00
  • 1 Year change+189.66%
  • Beta0.5129
Data delayed at least 15 minutes, as of Feb 13 2026 15:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.

  • Revenue in USD (TTM)2.61m
  • Net income in USD-386.75k
  • Incorporated2021
  • Employees4.00
  • Location
    QHSLab Inc901 Northpoint Parkway, Suite 302WEST PALM BEACH 33407United StatesUSA
  • Phone+1 (929) 379-6503
  • Websitehttps://www.usaqcorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nexalin Technology Inc156.94k-8.68m7.96m6.00--1.63--50.75-0.6345-0.63450.01090.26220.03020.300413.5926,156.67-167.17-166.16-178.46-334.5469.5176.06-5,530.09-1,178.9513.03--0.00--52.34-4.04-63.64------
Meihua International Medical Tech Co Ltd89.55m9.27m8.58m619.000.29310.01920.8730.095834.1234.12302.14520.790.484453.651.05144,664.905.029.695.9011.6934.3137.0210.3513.995.6689.960.06490.00-0.19494.01-6.73-6.81-56.87--
SeaStar Medical Holding Corp881.00k-13.67m8.83m19.00--0.7287--10.02-16.43-16.430.68743.360.0876--6.1046,368.42-135.86---290.37--95.35---1,551.08--3.64--0.00------5.34------
Tenon Medical Inc3.23m-12.81m9.11m27.00--4.20--2.82-2.76-2.760.57250.55760.27631.562.96119,740.70-109.47-174.04-149.09-976.4552.4034.39-396.26-788.171.70--0.00--11.92127.6112.25------
ALR Technologies SG Ltd9.49k-8.00m9.12m6.00------960.72-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
HeartSciences Inc8.67k-9.04m9.43m15.00--2.18--1,087.63-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
Movano Inc500.00k-17.05m9.44m32.00------18.88-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
PAVmed Inc29.00k-595.00k9.72m39.0026.3726.62--335.09-0.6822-0.68220.00051.550.0009--3.05743.594.17-115.648.14-8,726.29-520.69--4,931.04-3,891.34----0.2111--22.15--148.24--15.12--
REMSleep Holdings Inc12.27k-3.01m10.84m6.00--44.94--883.32-0.0019-0.00190.000010.00020.01930.8251.51---472.04-107.16-671.87-177.2194.87---24,509.54-1,456.221.73--0.2146---42.47--39.36--5.18--
QHSLab Inc2.61m-386.75k10.85m4.00------4.15-0.0373-0.03730.1997-0.05421.4926.3812.80653,480.00-22.10-39.97---284.7966.3755.22-14.80-44.620.17140.30381.63--51.31--44.65------
Beyond Air Inc6.92m-31.00m11.37m61.00--1.12--1.64-5.43-5.431.130.96510.19533.287.74113,508.20-90.33-81.28-107.51-103.401.82---462.58-4,167.724.77-13.320.7262--219.6721.6622.60--166.66--
SINTX Technologies Inc1.27m-16.56m11.56m20.00--2.67--9.10-6.93-6.930.58941.130.11211.345.5263,500.00-86.86-51.41-121.23-64.3452.0566.36-775.12-575.951.60-302.730.0143--9.9033.18-33.06--36.24--
BioNano Genomics Inc28.72m-38.59m11.60m98.00--0.2228--0.4039-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
Vicarious Surgical Inc0.00-53.59m13.52m123.00--0.8038-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
Phaos Technlgy Hldngs (Cayman) Limited132.40k-100.00bn13.62m--------102.88-------0.0602------------------------0.3176------------------
Data as of Feb 13 2026. Currency figures normalised to QHSLab Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.